Wintac: Updates on open offerGAVIS Pharma LLC, U.S.A together with Kali Capital LP, U.S.A. has acquired 15,12,098 equity shares of Wintac via open offer. Money Control, 34 minutes ago |
3,729 images for pharma | ||||
Time to nibble; bet on IT, auto, FMCG, pharma: EdelweissHe recommends putting money into FMCG, IT, pharma and auto stocks. "Another 50bps rate cut is likely by year- end, with fall in interest rates consumption theme should be back," he told CNBC-TV18 in an interview. Money Control, 42 minutes ago
|
BSE Sensex down 400 pts; Sun Pharma, Wipro outperformSun Pharma, TCS and Wipro are gainers in the Sensex as most stocks are reeling under selling pressure. Jindal Steel (down 6.34 percent), Hindalco, Tata Steel, ICICI Bank and Sterlie Industries are key losers in the Sensex. Money Control, 2 hours ago
BSE Sensex down 378 pts; Sun Pharma, TCS, Wipro outperform
Money Control, 5 hours ago
BSE Sensex, Nifty weak; banks, oil gas, pharma outperform
Money Control, 1 week ago
BSE Sensex flat; Hero, Wipro up 2%, Jindal Steel weak
Money Control, 1 week ago
|
Form 8-K MEI Pharma, Inc. For: Jun 18StreetInsider.com - Form 8-K MEI Pharma, Inc. For: Street Insider, 1 day ago
BioAlliance Pharma Begins Phase II Clinical Trial in the U.S. with Validive
Individual.com, 2 days ago
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Initiates Phase II Clinical Trial of Pracinostat and Vidaza in Frontline Myelodysplastic Syndrome
BioSpace, 1 day ago
MEI Pharma (MEIP) announces the dosing of the first patients in a Phase II trial of the myelodysplastic syndrome treatment Pracinostat, the company's lead candidate. CMO Robert Mass calls the initiation of Phase II clinicals "an important milestone." (PR)
Seeking Alpha, 1 day ago
|
Relatively Low PEG Ratio Detected in Shares of WuXi PharmaTech Cayman in the Life Sciences Tools & Services Industry (WX, ICLR, MTD, CRL, QGEN)(Comtex SmarTrend(R)) Below are the three companies in the Life Sciences Tools & Services industry with the lowest price to earnings to growth (PEG) ratios. PEG is valuable in assessing the tradeoff between the price of a stock and expected growth. Individual.com, 43 minutes ago
Jubilant Life board appoints an additional director
Myiris, 3 days ago
|
6/20/2013: FRONT PAGE: 146m euro fine on pharma firms for blocking cheap drugsBRUSSELS: Nine drugmakers, including Denmark's Lundbeck, were fined a total of 146 million euros by EU anti-trust regulators on Wednesday for blocking the supply of a cheaper antidepressant medicine to the Hindustan Times, 10 hours ago
EC fines 9 pharma companies, including Ranbaxy
The Statesman, 13 hours ago
Ranbaxy to appeal against EU fine
Money Today, 19 hours ago
European Commission fines Ranbaxy and 8 other pharma firms
ZeeNews.com, 21 hours ago
|
Elan Proceeds with Formal Sale Process of Company; Royalty Pharma Drops BidThe move follows rejection of Elan shareholders of certain key deals and withdrawal of Royalty Pharma bid. Elan announced on June 14, 2013, that it is proceeding with a formal sale process of the company and will invite Royalty Pharma, who had ... BioPharm International, 8 hours ago
Royalty Pharma Drops Judicial Review Request of Elan Bid
Bloomberg, 1 day ago
Royalty Pharma lets Elan takeover bid expire
Miami Herald, 1 day ago
Royalty Pharma drops hostile bid for Elan
Reuters, 1 day ago
More from: Denver Post, CNBC...and 74 other sources
|
Like pharma, FMCG and banking stocks: Vallabh Bhanshali, Enam SecuritiesIn an interview with ET Now, Vallabh Bhanshali, Chairman, Enam Securities, shares his view on the rupee and Mr Murthy's return as the chairman of Infosys. Excerpts: ET Now: Is the rupee telling us the true story? It is often believed in the past ... Economic Times, 3 hours ago
|
Buy Mahindra Ugine, IVRCL, Alembic Pharma: Rajesh AgarwalRajesh Agarwal of Eastern Financiers suggests buying Mahindra Ugine Steel Company, IVRCL, Lakshmi Vilas Bank and Alembic Pharmaceuticals. Money Control, 3 hours ago
|
Buy Sun Pharma with target price of Rs 980: Ashwani Gujraln a chat with ET Now, Ashwani Gujral, Fund Manager, Ashwanigujral.com , shares his views on Sun Pharma. What is your call on Sun Pharma? Buy Sun Pharma at a stop loss of Rs 948 and target Rs 980. Follow Economic Times Views/Recommendations Section, For The ... Economic Times, 5 hours ago
Buy Aurobindo Pharma Ltd with a target price of Rs 187: Sandeep Wagle
Economic Times, 2 days ago
Buy Sun Pharma with a target of Rs 1,015: Ashwani Gujral
Economic Times, 3 days ago
ICICI Sec retains Buy on Sun Pharma; cuts target to Rs 1,126
Myiris, 6 days ago
|